BioCentury | Feb 22, 2020
Product Development

Regenerative medicine for hearing loss makes quiet progress

...CDKN1B) - Cyclin-dependent kinase inhibitor 1B Selina Koch, Executive Editor; Winnie Pong, Associate Editor, Data & Analytics Cord Blood Registry Otonomy...
BioCentury | May 25, 2017
Translation in Brief

Youthful memories

...umbilical cord plasma proteins revitalize hippocampal function in aged mice." Nature (2017) Michael Leviten, Senior Writer Alkahest Inc. Cord Blood Registry Stanford...
BioCentury | Jan 4, 2016
Emerging Company Profile

Regrowing hearing

...Acousia plans to deliver its compounds locally to the inner ear. AMAG Pharmaceuticals Inc .'s Cord Blood Registry...
BioCentury | Sep 21, 2015
Company News

Cord Blood Registry, AMAG Pharmaceuticals deal

...Cord Blood Registry for $700 million in cash from private equity firm GTCR (see BioCentury, July 13). Cord Blood Registry...
BioCentury | Aug 13, 2015
Tools & Techniques

Helping Beethoven hear

...Ad5) to deliver the atonal homolog 1 (ATOH1; HATH1) gene Acquired hearing loss Phase I/II Cord Blood Registry...
BioCentury | Aug 1, 2015
Financial News

AMAG raises $200.8M in follow-on

...shares were valued at $64.95; AMAG lost $0.87 to $63.90 on Friday. AMAG is acquiring Cord Blood Registry...
BioCentury | Jul 13, 2015
Company News

Cord Blood Registry, AMAG Pharmaceuticals deal

...AMAG will acquire stem cell company Cord Blood Registry from private equity firm GTCR for $700 million in...
...from Jefferies and Barclays to fund the acquisition. AMAG reported $53.3 million in 2014 revenue. Cord Blood Registry...
BioCentury | Jun 30, 2015
Company News

AMAG acquires Cord Blood Registry

...AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) will acquire stem cell company Cord Blood Registry (San Bruno, Calif.) for $700 million...
BioCentury | Feb 27, 2012
Clinical News

Autologous umbilical cord blood: Phase I started

...months with acquired hearing loss. The trial is sponsored by the Memorial Hermann Healthcare System. Cord Blood Registry...
BioCentury | Feb 27, 2012
Clinical News

Autologous umbilical cord blood: Phase I/II started

...brain development disorder or obstructive hydrocephalus. The trial is sponsored by Georgia Health Sciences University. Cord Blood Registry...
Items per page:
1 - 10 of 10
BioCentury | Feb 22, 2020
Product Development

Regenerative medicine for hearing loss makes quiet progress

...CDKN1B) - Cyclin-dependent kinase inhibitor 1B Selina Koch, Executive Editor; Winnie Pong, Associate Editor, Data & Analytics Cord Blood Registry Otonomy...
BioCentury | May 25, 2017
Translation in Brief

Youthful memories

...umbilical cord plasma proteins revitalize hippocampal function in aged mice." Nature (2017) Michael Leviten, Senior Writer Alkahest Inc. Cord Blood Registry Stanford...
BioCentury | Jan 4, 2016
Emerging Company Profile

Regrowing hearing

...Acousia plans to deliver its compounds locally to the inner ear. AMAG Pharmaceuticals Inc .'s Cord Blood Registry...
BioCentury | Sep 21, 2015
Company News

Cord Blood Registry, AMAG Pharmaceuticals deal

...Cord Blood Registry for $700 million in cash from private equity firm GTCR (see BioCentury, July 13). Cord Blood Registry...
BioCentury | Aug 13, 2015
Tools & Techniques

Helping Beethoven hear

...Ad5) to deliver the atonal homolog 1 (ATOH1; HATH1) gene Acquired hearing loss Phase I/II Cord Blood Registry...
BioCentury | Aug 1, 2015
Financial News

AMAG raises $200.8M in follow-on

...shares were valued at $64.95; AMAG lost $0.87 to $63.90 on Friday. AMAG is acquiring Cord Blood Registry...
BioCentury | Jul 13, 2015
Company News

Cord Blood Registry, AMAG Pharmaceuticals deal

...AMAG will acquire stem cell company Cord Blood Registry from private equity firm GTCR for $700 million in...
...from Jefferies and Barclays to fund the acquisition. AMAG reported $53.3 million in 2014 revenue. Cord Blood Registry...
BioCentury | Jun 30, 2015
Company News

AMAG acquires Cord Blood Registry

...AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) will acquire stem cell company Cord Blood Registry (San Bruno, Calif.) for $700 million...
BioCentury | Feb 27, 2012
Clinical News

Autologous umbilical cord blood: Phase I started

...months with acquired hearing loss. The trial is sponsored by the Memorial Hermann Healthcare System. Cord Blood Registry...
BioCentury | Feb 27, 2012
Clinical News

Autologous umbilical cord blood: Phase I/II started

...brain development disorder or obstructive hydrocephalus. The trial is sponsored by Georgia Health Sciences University. Cord Blood Registry...
Items per page:
1 - 10 of 10